🎁 Black Friday: up to 50% off of annual plans
Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.37
-1.06 (-3.27%)
Nov 20, 2026, 4:00 PM EST - Market closed

Maze Therapeutics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Maze Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $62.46. The average 1-year stock price forecast is 99.11% higher than the current stock price, while the lowest is $46 (+46.64%) and the highest is $110 (+250.65%).

Price Target: $62.46 (+99.11%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$46$62.46$55$110
Change+46.64%+99.11%+75.33%+250.65%

Analyst Ratings

The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy111111121313
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total121212131414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$110
BuyMaintains$110+250.65%Nov 10, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$53 → $51
BuyReiterates$53 → $51+62.58%Nov 10, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$75
BuyMaintains$75+139.08%Nov 10, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$55
BuyReiterates$55+75.33%Nov 10, 2026
BTIG
BTIG
Buy
Maintains
$46
BuyMaintains$46+46.64%Nov 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
20.00M
Revenue Next Year
8.85M
from 20.00M
Decreased by -55.77%
EPS This Year
-2.79
from -3.05
EPS Next Year
-3.32
from -2.79
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--167.50M-20.00M
Gross Profit
--167.50M-20.00M
Gross Margin
--100.00%-100.00%
Operating Income
-111.03M-98.55M57.59M-142.90M-177.16M
Net Income
-114.94M-100.42M52.23M-131.12M-167.88M
EPS
----3.05-2.79
Free Cash Flow
----112.73M-96.40M
No. Analysts
----13
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High20.0M
Avg20.0M
Low20.0M

Revenue Growth

Revenue Growth20272028
High
200.0%
Avg
-55.8%
Low
-100.0%

EPS Forecast

EPS202620272028
High-2.16
Avg-2.79
Low-2.95

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-